State Attorneys General Express Concern Regarding HHS Pain Management Draft Report

Washington, D.C. — The National Association of Attorneys General (NAAG) has sent a letter to the U.S. Department of Health and Human Services (HHS) sharing concerns about the Pain Management Best Practices Inter-Agency Task Force Draft Report (Draft Report). The letter was addressed to Dr. Vanila Singh, chief medical officer for the Office of the Assistant Secretary for Health….

Read More →

Deadly Fentanyl Loophole Should be Closed by Passing Federal Legislation Endorsed by State and Territory Attorneys General

Washington, D.C. — The National Association of Attorneys General (NAAG) is endorsing federal legislation known as the Stopping Overdoses of Fentanyl Analogues (SOFA) Act (S.1553/H.R.4922). It would help address the opioid epidemic by closing a loophole that allows those who traffic deadly fentanyl, a synthetic opioid, to currently stay one step ahead of law enforcement. Fentanyl…

Read More →

AGs to Congress: Pass Legislation to Hold Irresponsible Opioid Manufacturers Accountable and Impose Stiffer Penalties

Washington, D.C. — In a continuing effort to help address the national opioid epidemic, the National Association of Attorneys General (NAAG) is calling on the U.S. Senate to quickly pass legislation that would hold opioid manufacturers accountable. Specifically, the Comprehensive Addiction and Recovery Act (CARA) 2.0 (S.2456) in addition to the Comprehensive Addiction Reform, Education, and…

Read More →

Attorneys General Urge Repeal of a Federal Law to Address Opioid Supply

Washington, D.C. — The National Association of Attorneys General (NAAG) sent a letter late yesterday to congressional leaders, urging them to repeal a 2016 federal law so registered drug manufacturers and distributors who have willfully contributed to the nation’s oversupply of pain killers (opioids), can be held accountable. The “Ensuring Patient Access and Effective Drug Enforcement…

Read More →

Attorneys General Support Federal Bill to Increase Access to Drug Addiction Treatment

Washington, D.C. — The National Association of Attorneys General (NAAG) is endorsing the federal bill, “Road to Recovery Act” (H.R. 2938) which will help address a lack of treatment for those suffering from drug addiction. The legislation will make treatment affordable for those who need it, and create market incentives for new treatment resources. America’s opioid…

Read More →

Attorneys General Urge Health Insurance Companies to Reduce Provider Incentives for Prescribing Pain Killers

Washington, D.C.—The National Association of Attorneys General (NAAG) sent a letter today to America’s Health Insurance Plans (AHIP), asking its insurance company members to review payment and coverage policies and revise them, as needed, to encourage healthcare providers to choose alternatives to prescribing prescription pain relievers known as opioids. Opioid overdoses kill 91 Americans every…

Read More →

Bridging the Gaps to Reduce Prescription Drug and Opioid Abuse and Misuse

While being in the throes of a national opioid abuse epidemic, a recently released NAGTRI report offers best and promising practices generated from a November 2016 Summit with law enforcement and public health officials. The link to a free website copy is provided.

Read More →

Attorneys General Call for Federal Legislation to Return Prescription Drug Settlement Money to the States

Washington, DC—The National Association of Attorneys General (NAAG) sent a letter today to the U.S. Senate Finance Committee chair and ranking member, asking them to introduce legislation that would allow the federal government to return prescription drug settlement money to the states. At issue is a prescription drug benefit, known as Medicare Part D, for…

Read More →

“First, Do No Harm”: Criminal Prosecutions of Doctors for Distributing Controlled Substances Outside of Legitimate Medical Need

NAGTRI revisited a 2007 study on physicians who had been prosecuted for prescribing controlled substances. The goal of this project was to determine if there had been any shift in the numbers of prosecutions, patient addictions, or states issuing opioid prescription guidelines since the 2007 study in an effort to curb the opioid abuse epidemic across the country.

Read More →